NASDAQ: CARECarter Bankshares Inc Stock
$14.78-0.04 (-0.27%)
Updated Apr 21, 2025
CARE Price
$14.78
Fair Value Price
$13.82
Market Cap
$341.88M
52 Week Low
$11.41
52 Week High
$20.40
P/E
13.94x
P/B
0.89x
P/S
2.85x
PEG
0.59x
Dividend Yield
N/A
Revenue
$140.87M
Earnings
$24.52M
Gross Margin
100%
Operating Margin
21.91%
Profit Margin
17.4%
Debt to Equity
11.12
Operating Cash Flow
$37M
Beta
0.96
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CARE Overview
Carter Bankshares, Inc. operates as the bank holding company for Carter Bank & Trust that provides various banking products and services. It accepts various deposit products, including checking, savings, retirement, and money market accounts, as well as longer-term certificates of deposits. The company also offers commercial loans comprising secured and unsecured loans; consumer loans, such as secured and unsecured loans for financing automobiles, home improvements, education, overdraft protection, and personal investments, as well as residential mortgages; real estate construction and acquisition loans; home equity lines of credit; and credit cards, as well as originates and holds fixed and variable rate mortgage loans. In addition, it provides other banking services that include safe deposit boxes, direct deposit of payroll and social security checks, online banking, bill pay, online account opening, mobile deposit, mobile banking, debit cards, e-statements, and ATM services; title insurance and other financial institution-related products and services; and treasury and corporate cash management services. It operates through 69 branches in Virginia and North Carolina. Carter Bankshares, Inc. was founded in 1974 and is headquartered in Martinsville, Virginia.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CARE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Bank
Industry Rating
F
CARE
Ranked#17 of 296
Ranked#17 of 296
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.60 | B | |
| $14.23 | B | |
| $30.90 | B |
Be the first to know about important CARE news, forecast changes, insider trades & much more!
CARE News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CARE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CARE ($14.78) is overvalued by 6.96% relative to our estimate of its Fair Value price of $13.82 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CARE ($14.78) is not significantly undervalued (6.96%) relative to our estimate of its Fair Value price of $13.82 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CARE ($14.78) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CARE due diligence checks available for Premium users.
Valuation
CARE fair value
Fair Value of CARE stock based on Discounted Cash Flow (DCF)
Price
$14.78
Fair Value
$13.82
Overvalued by
6.96%
CARE ($14.78) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CARE ($14.78) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CARE ($14.78) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CARE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
13.94x
Industry
13.07x
Market
27.14x
CARE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CARE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CARE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.89x
Industry
1.07x
CARE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CARE price to earnings growth (PEG)
For valuing profitable companies with growth potential
CARE is good value based... subscribe to Premium to read more.
PEG Value Valuation
CARE's financial health
Profit margin
Revenue
$39.5M
Net Income
$8.3M
Profit Margin
20.9%
CARE's Earnings (EBIT) of $30.87M... subscribe to Premium to read more.
Interest Coverage Financials
CARE's profit margin (17.4%) has... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.7B
Liabilities
$4.3B
Debt to equity
11.12
CARE's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CARE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$11.5M
Investing
-$33.6M
Financing
$48.4M
CARE's operating cash flow ($36.94M)... subscribe to Premium to read more.
Debt Coverage Financials
CARE vs Bank Stocks
Carter Bankshares Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.